Picture of Avivagen logo

VIV.H Avivagen Share Price

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m+3.05%
3m+0.92%
6m-52.35%
1yr-93.41%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-650.75%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Oct 202331st Oct 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Avivagen EPS forecast chart

Profile Summary

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

Directors

Last Annual
October 31st, 2022
Last Interim
July 31st, 2023
Incorporated
November 1st, 2017
Public Since
March 4th, 2004
No. of Employees
12
Sector
Food & Tobacco
Industry
Consumer Defensives
Exchange
ca flag iconTSX Venture Exchange
Shares in Issue
77,694,700

VIV.H Share Price Performance

Upcoming Events for VIV.H

Q1 2024 Avivagen Inc Earnings Release

Avivagen Inc Annual Shareholders Meeting

Q3 2024 Avivagen Inc Earnings Release

Similar to VIV.H

Picture of BioNeutra Global logo

BioNeutra Global

ca flag iconTSX Venture Exchange

Picture of Canyon Creek Food logo

Canyon Creek Food

ca flag iconTSX Venture Exchange

Picture of CubicFarm Systems logo

CubicFarm Systems

ca flag iconTSX Venture Exchange

Picture of Deveron logo

Deveron

ca flag iconTSX Venture Exchange

Picture of DLC Holdings logo

DLC Holdings

ca flag iconTSX Venture Exchange

FAQ